Company: INTS
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001567264-25-000077
Chunk: 58

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 8
Chunk 58
---
% of the aggregate number of shares of common stock outstanding on the final day of the preceding calendar year, or (b) such smaller amount as determined by the Board. On January 1, 2023 and January 1, 2024, an additional 238,700 and 479,828 shares were authorized under the 2021 Plan. On January 1, 2025, an additional 529,300 shares were authorized under the 2021 Plan. As of June 30, 2025, 957,277 shares were available for issuance under the 2021 Plan.The Company recorded total stock-based compensation for its outstanding stock options and warrants in its Statements of Operations as follows (in thousands):Three Months EndedJune 30,Six Months Ended June 30,2025202420252024Research and development$263 $217 $423 $783 General and administrative381 374 656 963 Total stock-based compensation expense$644 $591 $1,079 $1,746 Stock optionsThe following table summarizes the range of assumptions used to estimate the fair value of stock options issued using the Black-Scholes-Merton option pricing model:Six Months Ended June 30,20252024Stock price$0.57$3.76 to $5.19Exercise price$0.57$3.76 to $5.19Expected volatility106.8% to 107.9%97.1% to 101.6%Risk free interest rates4.1% to 4.6%4.1% to 4.5%Expected term (years)6.5 to 75 to 7

9

For the six months ended June 30, 2025 and 2024, a dividend yield of 0% was used because the Company has not historically paid and does not intend to pay a dividend on common stock in the foreseeable future. The expected stock price volatility assumption was estimated based on the historical volatilities for industry peers, as the Company had no active market for its stock prior to the IPO and limited history for issuance price of its stock. The risk-free rate assumption is determined using the yield currently available on U.S. Treasury zero coupon issues with a remaining term commensurate with the expected term of the award. The expected term of the option represents the period the options are expected to be outstanding.The following table summarizes the activity for stock options under the 2013 and 2021 Plans for